4Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China[J].Journal of Hepatology, 2009, (50) :204.
5Brunt EM, Neuschwander-Tetri BA, Oliver D, et al.Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens[J]. Hum Pathol,2004, 35(9) : 1 070.
6Miller Er 3rd, Pastor-Barriuso R, Dalal D, et al.Meta-analysis; high-dosage vitamin E supplementation may in- crease all-cause mortality[J].Ann lntern Med, 2005, 142 (1):37.
7Aldo FH, Patricia V TD, Marco A JO. Hepatoprotective effects of Spirulina maxima in patients with non-alcoholicfatty liver disease: a case series[J]. Journal of Medical Case Reports, 2010,4 : 103.
8Lirussi F, Mastropasqua E, Orando S, et al. Probiotics for non -alcoholic fatty liver disease and/or steatohepatitis [J].Cochrane Database Syst Rev, 2007,24( 1 ) : CD005165.
